1. An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence
    Lisa Padroni et al, 2023, International Journal of Molecular Sciences CrossRef
  2. Direct, precise, enzyme-free detection of miR-103–3p in real samples by microgels with highly specific molecular beacons
    Sabrina Napoletano et al, 2023, Talanta CrossRef
  3. The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application
    Juan P. Muñoz et al, 2023, Diagnostics CrossRef
  4. Potential utility of miRNAs for liquid biopsy in breast cancer
    Xiangrong Liu et al, 2022, Frontiers in Oncology CrossRef
  5. Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
    Carmina Jiménez-Ramírez et al, 2022, PLOS ONE CrossRef
  6. MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
    Tamyres Mingorance Carvalho et al, 2022, Frontiers in Genetics CrossRef
  7. Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens – pilot study
    Anna Puła et al, 2024, Leukemia & Lymphoma CrossRef
  8. miR482f and miR482c-5p from edible plant-derived foods inhibit the expression of pro-inflammatory genes in human THP-1 macrophages
    Ester Díez-Sainz et al, 2023, Frontiers in Nutrition CrossRef
  9. miRNAs as biomarkers in human diseases
    Rümeysa KARAİSMAİLOĞLU et al, 2022, International Journal of Science Letters CrossRef
  10. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
    Dan Xie et al, 2022, Frontiers in Endocrinology CrossRef
  11. Integrated analysis of diverse cancer types reveals a breast cancer-specific serum miRNA biomarker through relative expression orderings analysis
    Liyuan Ma et al, 2024, Breast Cancer Research and Treatment CrossRef
  12. METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
    Zhiyang Zhou et al, 2023, Epigenetics CrossRef